Jump to content
Advertisement

Advertisement
Jeffrey Roberts

Medical and Psychological Comorbidities Influencing Therapeutic Choices (DDW19)

Recommended Posts

Jeffrey Roberts

Advertisement

L Chang: Wide prevalence of comorbid conditions in IBS. Quality of Life (QOL) suffers with the greater number of conditions

L Chang: FGiDs (Functional Gastrointestinal Disorders) and IBS comorbidities especially significant for women

1508823824_Chang-comorbidities.thumb.jpg.b9521751d093acbf2ae59b55695a6ec4.jpg

1312857230_Chang-femalecomorbidities.thumb.jpg.6f68fddbde264765a27e325b21c92629.jpg

L Chang: Role for central neuromodulators (antidepressants) for managing FGiDs and IBS

1575766566_Chang-neuromodulators.jpg.ab7016def236c73fff680d47c8d33992.jpg

L Chang: Tricyclic antidepressants are considered first line for pain modulation. SSRI's antidepressants not as effective for GI pain. SNRI's antidepressants effective for pain. Tetracyclic antidepressants for early satiety, nausea/vomiting, weight loss and sleep disturbance

IMG_0888.jpg.b27a8012dee3b987266ae987f354f829.jpg

L Chang: New data with pregabalin (Lyrica) for greater than 3 FGiD pain attacks per month. Could be considered for pain

L Chang: Co-morbid migraine: CGRP receptor antagonist for IBS-D/M might be an option



Advertisement

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


×
×
  • Create New...